Valentine Delabie

Diagnostics for Animals is the representative World Federation of the Veterinary Diagnostic Industry.

• We explain the benefit of our products,
• We Work for a harmonized, efficient, and transparent regulatory framework
• We promote Innovation in emerging diseases or responsible prescription of antibiotics
• We dialogue and collaborate with other Animal Health institutions and stakeholders.

Do you want to showcase your expertise and increase your visibility among key stakeholders in Life Sciences?

Exhibiting at BioFIT 2025 positions your organisation at the heart of the early-stage innovation ecosystem and allows you to:
✔ Meet international biotech, pharma and animal health decision-makers
✔ Maximise your business opportunities through informal meetings
✔ Promote your assets, services, and early-stage innovations
✔ Expand your visibility among potential partners and investors

Provaxs is the leading business development center at Ghent University, dedicated to advancing animal health. We bridge the gap between industry and academia, fostering collaborations that drive the transfer of groundbreaking technologies. Their focus is on developing innovative solutions to enhance animal health and welfare.

The BioFIT 2025 conference programme is now available! Join us on December 2^nd & 3^rd to explore the most pressing issues in biotech innovation and Life Sciences. This year’s agenda is designed to foster collaboration and create new opportunities for researchers, entrepreneurs, investors and industry leaders.

As an independent company active in both human and animal health, Boehringer Ingelheim has learned over generations that the challenging path towards health innovation requires long-term commitment, resilience, and transformative action. Decades of cutting-edge science and innovation has enabled them to deliver many pioneering breakthroughs in some of the most devastating diseases and challenging areas we face globally. Continuing this journey hinges on collaboration.

They believe that working together with their global community of partners brings critical diversity to innovation and accelerates the next breakthroughs in human and animal health that will transform lives now and in generations to come. This collective power, in the tireless pursuit of science and solutions, enables them to build together a healthier, more sustainable, and equitable tomorrow.

Founded in 2012, X’PROCHEM is a CRO (Contract Research Organisation) specialised in chemical protein synthesis.

They design and produce therapeutic proteins for their pharmaceutical and biotech partners. They manufacture complex and highly customised proteins up to 400 amino acids (40 kDa) by using an automated process.

We are delighted to welcome Ceva Santé Animale as a Silver Sponsor of BioFIT 2024.  

Ceva, a leading global player in animal health, is an independent French company at the forefront of innovation in France, Europe and worldwide. Ceva is dedicated to advancing animal health solutions, from cutting-edge vaccines to revolutionary biotech and pharmaceuticals applications. 

Ceva’s mission is to provide innovative health solutions for all animals to ensure the highest level of care and well-being, driven by the #OneHealth approach – the understanding that the health of people, animals and the planet are interconnected.  Ceva’s comprehensive product range includes health solutions for numerous animal species (both farm and companion animals), as well as equipment, training, technical support and smart services. 

Ceva is pioneer in preventive health, investing 54% of its R&D budget into developing preventive solutions, including groundbreaking work in mRNA vaccine technology. With over 25 years of experience, Ceva is also globally recognized for its pharmaceutical expertise, particularly in small-molecules development for complex diseases such as cardiophatologies or behavior disorders.